Biomerica (BMRA) EPS (Basic) (QoQ) (2011 - 2026)
Biomerica (BMRA) EPS (Basic) (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | Biomerica | 4.97 Mn | 3.63 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 3.98% |
| Nov 30, 2025 | -59,984.56% |
| Aug 31, 2025 | 100.11% |
| May 31, 2025 | -38.43% |
| Feb 28, 2025 | -9.25% |
| Nov 30, 2024 | 29.08% |
| Aug 31, 2024 | -6.90% |
| May 31, 2024 | 35.82% |
| Feb 29, 2024 | -27.27% |
| Nov 30, 2023 | -33.13% |
| Aug 31, 2023 | 59.01% |
| May 31, 2023 | -34.15% |
| Feb 28, 2023 | -1.28% |
| Nov 30, 2022 | 23.59% |
| Aug 31, 2022 | -13.95% |
| May 31, 2022 | -1,608.21% |
| Feb 28, 2022 | 90.91% |
| Nov 30, 2021 | 28.01% |
| Aug 31, 2021 | 54.57% |
| May 31, 2021 | -53.10% |